Jutba, Feliciano .

HRN: 05-51-29  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/20/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/20/2023
07/30/2023
IV
500mg
Q8hr
Empiric
Waiting Final Action 

Indication:  Empiric    Type of Infection:  PneumoniaURTI    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: